fda deadline for compounded semaglutide shortage ends as sets compounders FDA sets tirzepatide compounding deadlines

Both forms of semaglutide have shown effectiveness in promoting weight loss when used as part of a comprehensive weight management program that includes diet and exercise

P.BresolinN.CortiS

Arsenic trioxide sensitivity is associated with low level of glutathione in cancer cells

Participants taking the highest dose of Eli Lillys new GLP-1 drug lost an average of 28.7% of their body weight in a late-stage trial, putting it on track to be a heavyweight in the crowded world of weight-loss and diabetes treatments

Canadas health department stated that it would monitor the availability of diabetes and weight-loss drugs, and that current regulations prevent companies from exporting drugs intended for domestic markets if it would cause or worsen a shortage